Home › Studies › PRJEB42304
PRJEB42304 ERP126142

Fecal microbiome in IBS vs controls, case-control, Ireland

Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption

139 fecal samples from adults in Ireland, comparing people with irritable bowel syndrome (including bile acid malabsorption) to matched controls, using shotgun and 16S sequencing; case-control design. machine-written summary

139 samples · 139 runs · IE · Adult · 2021 · 4.73 Gbp / sample

Sources
✓Sequence archive 556○Abstract / description○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive556 sample values (collection date, country, health condition, health condition detail)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC10154212, PMC11538712
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
adult139
Condition
ibs80
healthy_control59
Country
IE139
Body site
primary139
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 2 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 136 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 1 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.73 Gbp per sample0130Gbp
Community composition
Bacteroides 8.1%Faecalibacterium 7.1%Roseburia 6.2%Phocaeicola 5.6%Alistipes 3.5%Blautia_A 3.3%Prevotella 3.1%Ruminococcoides 2.6%Vescimonas 2.2%Gemmiger 2.1%Dialister 2.0%Lachnospira 1.9%not assigned to a genus 5.2%other genera 47.2%

Genera, mean relative abundance over 122 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category139 100%
country139 100%139
health_condition139 100%139
subject_id0 0%
collection_date139 100%139
health_condition_detail139 100%139
Papers (3)
  • Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption. 2020 PMID 31843589 own_data
  • Toward an improved definition of a healthy microbiome for healthy aging. 2022 PMID 37118093 PMC10154212 unsure
  • Cross-Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment. 2024 PMID 39243395 PMC11538712 unsure
Details
Archive description

Irritable bowel syndrome (IBS) is a heterogeneous disorder, but diagnoses and determination of subtypes are made based on symptoms. We profiled the fecal microbiomes of patients with and without IBS to identify biomarkers of this disorder. We collected fecal and urine samples from 80 patients with IBS (Rome IV criteria 16-70 years old) and 65 matched individuals without IBS (control individuals), along with anthropometric, medical, and dietary information. Shotgun and 16S ribosomal RNA amplicon sequencing were performed on feces.Patients with IBS had significant differences in network connections between diet and fecal microbiomes compared with control individuals these were accompanied by differences in fecal metabolomes. We did not find significant differences in fecal microbiota composition among patients with different IBS symptom subtypes. Despite the heterogeneity of IBS, patients have significant differences in urine and fecal metabolomes and fecal microbiome vs control individuals, independent of symptom-based subtypes of IBS.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.62. Assay shotgun_dna.

  • host run.scientific_name · “human gut metagenome”
  • body site run.scientific_name · “human gut metagenome”
  • life stage study.description · “16-70 years old”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA7756187collection_date2017R10.90biosample.attribute:collection_date2017
SAMEA7756187countryIER10.90sample.attr.geographic_location_country_and_or_seaIreland
SAMEA7756187health_conditionibsR10.70sample.name_rule:aliasSample_WGS_IBS_S0049
SAMEA7756187health_condition_detailIBSR10.70sample.name_rule:aliasSample_WGS_IBS_S0049
Sequencing

139 runs over 139 samples · mean 4.89 Gbp per run (median 4.73 Gbp, total 679.79 Gbp; 139 runs with a base count) · layout PAIRED 139 · platform ILLUMINA 139 · models Illumina HiSeq 2500 (139) · 88% of runs with a Sandpiper profile · first public 2021-01-08

Authors (15)

Jeffery IB first · Das A · O'Herlihy E · Coughlan S · Cisek K · Moore M · Bradley F · Carty T · Pradhan M · Dwibedi C · Shanahan F · O'Toole PW last · Ghosh TS first · Li J first · Arendt E

Downloads

PRJEB42304.csv.gz (4.0 KB) · parquet (74.3 KB) — all 139 samples, every field with route and confidence · PRJEB42304_determinations.csv.gz (4.4 KB) — 556 evidence rows

Samples (139 · every field this project has values for · hover a cell for its source)
Loading the sample table…